Señales en vivo de ALKS | Maximiza tus Ganancias con Getagraph.com

VENDER 426 min ago

@ $24.17

Emitido: 9 may 2024 @ 14:22

Retorno: 0.37%

Señal anterior: may 9 - 11:46

Señal anterior: Comprar

Retorno: 0.04 %

Live Chart Being Loaded With Signals

Commentary (9 may 2024 @ 16:00):

Stats
Volumen de hoy	955 297
Volumen promedio	2.09M
Capitalización de mercado	4.05B
EPS	$0 ( 2024-04-24 )
Próxima fecha de ganancias	( $0.700 ) 2024-07-22
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	7.93
ATR14	$0.360 (1.48%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Lurker Nancy	Buy	22 103	Non Qualified Stock Option (Right to Buy)
2024-04-11	Lurker Nancy	Buy	11 255	Restricted Stock Unit Award
2024-04-11	Lurker Nancy	Buy	4 833	Non Qualified Stock Option (Right to Buy)
2024-04-11	Lurker Nancy	Buy	2 323	Restricted Stock Unit Award
2024-03-18	Nichols Christian Todd	Sell	10 417	Ordinary Shares

INSIDER POWER
75.16
Last 99 transactions
Buy: 1 207 179 \| Sell: 170 568

Volumen Correlación

Largo: 0.80 (strong)

Corto: 0.33 (neutral)

Signal:(40) Neutral

Alkermes Plc Correlación

10 Correlaciones Más Positivas
BLPH	0.935
ETNB	0.93
RCM	0.928
XGN	0.926
RNEM	0.923
GMVD	0.922
DBVT	0.917
NUZE	0.916
CGEN	0.915
NVCT	0.912

10 Correlaciones Más Negativas
QADB	-0.914
WNEB	-0.905
EBACU	-0.899
MPRA	-0.898
PKOH	-0.898
DRNA	-0.898
JNCE	-0.895
MLAI	-0.892
SQQQ	-0.892
VS	-0.886

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Alkermes Plc Correlación - Moneda/Commodity

0.27
( neutral )

0.68
( moderate )

0.00
( neutral )

0.18
( neutral )

0.84
( strong )

-0.09
( neutral )

Alkermes Plc Finanzas

Annual	2023
Ingresos:	$1.66B
Beneficio Bruto:	$1.37B (82.64 %)
EPS:	$2.14

FY	2023
Ingresos:	$1.66B
Beneficio Bruto:	$1.37B (82.64 %)
EPS:	$2.14

FY	2022
Ingresos:	$1.11B
Beneficio Bruto:	$893.69M (80.38 %)
EPS:	$-0.970

FY	2021
Ingresos:	$1.17B
Beneficio Bruto:	$569.84M (48.55 %)
EPS:	$-0.300

Financial Reports:

No articles found.

Alkermes Plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and prevention of opioid dependence; RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorder; INVEGA SUSTENNA for the treatment of schizophrenia and schizoaffective disorder; XEPLION, INVEGA TRINZA, and TREVICTA to treat schizophrenia and schizoaffective; and VUMERITY for the treatment of relapsing forms of multiple sclerosis in adults, including clinically isolated syndrome, relapsing-remitting and active secondary progressive diseases. The company is also developing LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and nemvaleukin alfa, an engineered fusion protein to expand tumor-killing immune cells and to avoid the activation of immunosuppressive cells. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.